Circulating Antibodies against Epstein-Barr Virus (EBV) and p53 in EBV-Positive and -Negative Gastric Cancer.
M Constanza CamargoKyoung-Mee KimKeitaro MatsuoJavier TorresLinda M LiaoDouglas MorganAngelika MichelTim WaterboerMinkyo SongMargaret L GulleyRicardo L DominguezYasushi YatabeGustavo Cortes-MartinezJolanta LissowskaJovanny ZabaletaMichael PawlitaCharles S RabkinPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2019)
Anti-EBV and anti-p53 antibodies are differentially associated with tumor EBV positivity. Serology may identify EBV-positive gastric cancer for targeted therapies.